RT-LAMP Assays
Molecular detection of SARS-CoV-2, Influenza A/B
CommercialActive
Key Facts
Indication
Molecular detection of SARS-CoV-2, Influenza A/B
Phase
Commercial
Status
Active
Company
About Coris Bioconcept
Coris BioConcept is a specialized diagnostics company with a 25-year history, operating from Gembloux, Belgium. It has established a niche in rapid tests for infectious diseases, particularly building a comprehensive suite of products for detecting carbapenemase and other antibiotic resistance mechanisms, which are critical in combating antimicrobial resistance (AMR). The company leverages multiple technology platforms—immunochromatography (lateral flow), electrochemistry, and RT-LAMP—to serve clinical, veterinary, and public health markets. As a private, revenue-generating SME, Coris competes by addressing specific, high-need diagnostic gaps with its portfolio of commercialized tests.
View full company profile